(Q37687415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Oncolytic (replication-competent) adenoviruses as anticancer agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Debanjan Dhar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

William S M Wold

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

353-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Oncolytic viral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

The impact of adenovirus infection on the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenoviruses: update on structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus protein VI mediates membrane disruption following capsid disassembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Association of adenovirus with the microtubule organizing center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Functions of the adenovirus E4 proteins and their impact on viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Viruses - seeking and destroying the tumor program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Current advances and future challenges in Adenoviral vector biology and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus serotype 5 hexon mediates liver gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Development of PEGylated adenovirus vector with targeting ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

21 January 2018

Telomeres and disease

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Virology- and immunology-based gene therapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

The tumour microenvironment: a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Genetic identification of adenovirus type 5 genes that influence viral spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Developing novel oncolytic adenoviruses through bioselection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Subcutaneous Administration of a Replication-Competent Adenovirus Expressing HSV-tk to Cotton Rats: Dissemination, Persistence, Shedding, and Pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Clinical trials with oncolytic adenovirus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

China approves world's first oncolytic virus therapy for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Prostate cancer gene therapy clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Inefficient killing of quiescent human epithelial cells by replicating adenoviruses: potential implications for their use as oncolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

Emerging Infections: Adenovirus Infections in Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903559822

10.1517/14712590903559822

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20132057%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference